NewAmsterdam Pharma Company N.V.

NAMS stock score: 39/100

$21.58 · +0.42% · Scored Oct 22, 2026

Technical
39
Fundamental
38
News
38

The reading

NewAmsterdam Pharma Company (NAMS) scores 39 out of 100, which reads bearish, higher than 30% of Healthcare stocks and 16% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 39, fundamentals 38.

Among the fundamentals, Fair Value at 100 and Quick Ratio at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 29 and contrarian oscillators 56 — a split worth reading before trusting the technical total.

News sentiment is negative at 38; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 35 to 63, and it is down 18 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward NAMS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

38

Pulling it up

  • Fair Value100

    Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Growth (Quarterly)0

    Quarterly earnings growth measures profit increase versus the prior-year quarter.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

35 weighted scorers; 6 had no data today and are left out rather than counted as zero.

Technical · daily

31

Pulling it up

  • Candlestick Patterns100

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Money Flow Index (14)90

    Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • MACD (12)85

    Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.

Holding it back

  • S&P 500 52W Comparison0

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • SMA 2000

    Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

  • SMA 1000

    Simple Moving Average (100-period) provides a longer-term perspective on price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
38

Technical score by timeframe

ChartScoreWeight
Hourly501
Daily313
Weekly292
Monthly412
Quarterly532

Composite score, last 90 days

05010039Jul 25, 2026Oct 22, 2026Jul 25, 2026: 57Jul 26, 2026: 57Jul 27, 2026: 62Jul 28, 2026: 61Jul 29, 2026: 61Jul 30, 2026: 61Jul 31, 2026: 63Aug 2, 2026: 47Aug 3, 2026: 48Aug 5, 2026: 45Aug 6, 2026: 47Aug 7, 2026: 44Aug 8, 2026: 44Aug 9, 2026: 44Aug 10, 2026: 44Aug 11, 2026: 44Aug 12, 2026: 44Aug 13, 2026: 42Aug 14, 2026: 44Aug 15, 2026: 43Aug 16, 2026: 42Aug 17, 2026: 43Aug 18, 2026: 43Aug 19, 2026: 47Aug 20, 2026: 46Aug 22, 2026: 44Aug 23, 2026: 44Aug 24, 2026: 41Aug 25, 2026: 42Aug 26, 2026: 42Aug 27, 2026: 42Aug 28, 2026: 40Aug 29, 2026: 40Aug 30, 2026: 40Aug 31, 2026: 42Sep 1, 2026: 40Sep 2, 2026: 41Sep 3, 2026: 41Sep 4, 2026: 38Sep 5, 2026: 39Sep 6, 2026: 39Sep 7, 2026: 38Sep 8, 2026: 41Sep 9, 2026: 38Sep 10, 2026: 37Sep 11, 2026: 39Sep 12, 2026: 39Sep 13, 2026: 39Sep 14, 2026: 39Sep 15, 2026: 38Sep 16, 2026: 37Sep 17, 2026: 39Sep 18, 2026: 39Sep 19, 2026: 39Sep 20, 2026: 39Sep 21, 2026: 40Sep 22, 2026: 41Sep 23, 2026: 41Sep 24, 2026: 41Sep 25, 2026: 39Sep 26, 2026: 40Sep 27, 2026: 40Sep 28, 2026: 41Sep 29, 2026: 42Sep 30, 2026: 42Oct 1, 2026: 42Oct 2, 2026: 40Oct 3, 2026: 41Oct 4, 2026: 41Oct 5, 2026: 39Oct 6, 2026: 38Oct 7, 2026: 39Oct 8, 2026: 37Oct 9, 2026: 38Oct 10, 2026: 38Oct 11, 2026: 38Oct 12, 2026: 37Oct 13, 2026: 36Oct 14, 2026: 36Oct 15, 2026: 37Oct 16, 2026: 35Oct 17, 2026: 35Oct 18, 2026: 35Oct 19, 2026: 37Oct 20, 2026: 39Oct 21, 2026: 40Oct 22, 2026: 39
Show the daily numbers
DateComposite
Oct 22, 202639
Oct 21, 202640
Oct 20, 202639
Oct 19, 202637
Oct 18, 202635
Oct 17, 202635
Oct 16, 202635
Oct 15, 202637
Oct 14, 202636
Oct 13, 202636
Oct 12, 202637
Oct 11, 202638
Oct 10, 202638
Oct 9, 202638
Oct 8, 202637
Oct 7, 202639
Oct 6, 202638
Oct 5, 202639
Oct 4, 202641
Oct 3, 202641
Oct 2, 202640
Oct 1, 202642
Sep 30, 202642
Sep 29, 202642
Sep 28, 202641
Sep 27, 202640
Sep 26, 202640
Sep 25, 202639
Sep 24, 202641
Sep 23, 202641
Sep 22, 202641
Sep 21, 202640
Sep 20, 202639
Sep 19, 202639
Sep 18, 202639
Sep 17, 202639
Sep 16, 202637
Sep 15, 202638
Sep 14, 202639
Sep 13, 202639
Sep 12, 202639
Sep 11, 202639
Sep 10, 202637
Sep 9, 202638
Sep 8, 202641
Sep 7, 202638
Sep 6, 202639
Sep 5, 202639
Sep 4, 202638
Sep 3, 202641
Sep 2, 202641
Sep 1, 202640
Aug 31, 202642
Aug 30, 202640
Aug 29, 202640
Aug 28, 202640
Aug 27, 202642
Aug 26, 202642
Aug 25, 202642
Aug 24, 202641
Aug 23, 202644
Aug 22, 202644
Aug 20, 202646
Aug 19, 202647
Aug 18, 202643
Aug 17, 202643
Aug 16, 202642
Aug 15, 202643
Aug 14, 202644
Aug 13, 202642
Aug 12, 202644
Aug 11, 202644
Aug 10, 202644
Aug 9, 202644
Aug 8, 202644
Aug 7, 202644
Aug 6, 202647
Aug 5, 202645
Aug 3, 202648
Aug 2, 202647
Jul 31, 202663
Jul 30, 202661
Jul 29, 202661
Jul 28, 202661
Jul 27, 202662
Jul 26, 202657
Jul 25, 202657

Key facts

Market cap
$2.5B
Sector
Healthcare
Industry
Biotechnology
Beta
0.10
Risk grade (1–10)
—
Next earnings
Nov 4, 2026

Biotechnology peers

CompanyMarket capScore
MRVI Maravai LifeSciences$2.6B44
VRDN Viridian Therapeutics$2.6B48
BEAM Beam Therapeutics$2.5B39
ZLAB Zai Lab$2.5B37
ADMA ADMA Biologics$2.5B62
RCUS Arcus Biosciences$2.4B36

Questions

What is NAMS's stock score today?

NAMS scores 39/100 (Bearish) as of Oct 22, 2026: technical 39, fundamental 38, and news sentiment 38, which is shown but not counted. Scores are recomputed every night.

Is NAMS a buy?

The score is not a buy or sell recommendation. A 39 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the NAMS score calculated?

97 weighted scorers feed it today: 35 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.